The CCL22-mediated FAK addiction in ESCC cells implies that TME-derived cytokines can prime the responsiveness of cancer cells to protein tyrosine kinase-based targeted therapies by inducing oncogene addiction and indicates that an immunosuppressive TME may be the critical switch to mediate oncogene addiction. This evidence concerns the gene PTK2 and esophageal squamous cell carcinoma.